Kirsche H, Klimek L
Universitätsklinikum Münster, Klinik für Hals-Nasen-Ohrenheilkunde, Kardinal-von-Galen-Ring 10, 48149, Münster, Deutschland,
HNO. 2015 May;63(5):357-63. doi: 10.1007/s00106-015-0008-7.
A differential diagnosis of persistent chronic rhinosinusitis is ASA-intolerance syndrome (AIS), also known as Aspirin®‑exacerbated respiratory disease (AERD), Samter-Trias (Samter's disease, Morbus Widal). Particularly in cases of frequent recurrency of nasal polyps in combination with bronchial asthma and hypersensitivity reactions to acetylsalicylic acid (ASA) and other nonsteroidal anti-inflammatory drugs (NSAR) can often be referred to an underlying AIS. The pathogenesis of this syndrome is attributed to a misallocation of the arachidonic acid metabolism, resulting in an increased leukotriene production.
The diagnosis may be difficult in the early stages of the disease with incomplete triad of symptoms.
Therapy may consist of paranasal sinuses surgery, drug therapy and adaptive deactivation as the only causal treatment option for patients with AIS.
For adaptive desactivation, positive effects were actually shown even in patients with long-term recurrent or persistent complaints of chronic rhinosinusitis.
持续性慢性鼻窦炎的鉴别诊断包括阿司匹林不耐受综合征(AIS),也称为阿司匹林加重性呼吸系统疾病(AERD)、桑特三联征(桑特氏病、维达尔病)。特别是在鼻息肉频繁复发并伴有支气管哮喘以及对乙酰水杨酸(ASA)和其他非甾体类抗炎药(NSAR)过敏反应的情况下,往往提示存在潜在的AIS。该综合征的发病机制归因于花生四烯酸代谢的紊乱,导致白三烯生成增加。
在疾病早期症状三联征不完全时,诊断可能困难。
治疗可能包括鼻窦手术、药物治疗和适应性失敏,这是AIS患者唯一的病因治疗选择。
对于适应性失敏,即使是长期反复或持续存在慢性鼻窦炎主诉的患者,实际上也显示出了积极效果。